As of 2025-07-11, the Intrinsic Value of Medifast Inc (MED) is 25.92 USD. This Medifast valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 14.68 USD, the upside of Medifast Inc is 76.60%.
The range of the Intrinsic Value is 20.99 - 39.85 USD
Based on its market price of 14.68 USD and our intrinsic valuation, Medifast Inc (MED) is undervalued by 76.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 20.99 - 39.85 | 25.92 | 76.6% |
| DCF (Growth 10y) | 22.73 - 42.20 | 27.85 | 89.7% |
| DCF (EBITDA 5y) | 18.07 - 20.98 | 19.43 | 32.3% |
| DCF (EBITDA 10y) | 20.01 - 23.62 | 21.66 | 47.5% |
| Fair Value | -3.18 - -3.18 | -3.18 | -121.68% |
| P/E | (10.92) - 11.09 | (2.37) | -116.2% |
| EV/EBITDA | 18.37 - 26.57 | 21.70 | 47.8% |
| EPV | 117.34 - 157.26 | 137.30 | 835.3% |
| DDM - Stable | (4.87) - (16.97) | (10.92) | -174.4% |
| DDM - Multi | 5.56 - 15.80 | 8.32 | -43.3% |
| Market Cap (mil) | 161.33 |
| Beta | 0.55 |
| Outstanding shares (mil) | 10.99 |
| Enterprise Value (mil) | 69.62 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.26% |
| Cost of Debt | 5.00% |
| WACC | 6.04% |